can i use my fsa for glp 1 medication Is GLP-1 Eligible? Weight Loss Coverage Options Shed Nutrition GLP-1 Boost by

Description

If youre considering starting or switching medications, it helps to understand the differences between common options

At a Glance Medications Offered Ozempic (semaglutide) weekly injection Wegovy (semaglutide) FDA-approved for weight loss Zepbound (tirzepatide) dual GIP/GLP-1 agonist Brand-Name Only No Compounding Cost & Insurance First month: $45 Ongoing: $145/month membership 6-month total: ~$770 (membership only) Insurance: Concierge support to help you get coverage Self-pay: Available for cash-pay options Whats Included Licensed provider consultations At-home metabolic lab testing Registered dietitian access Ongoing clinical check-ins Insurance navigation support Delivery & Access Format: Telehealth + medication delivery Availability: Nationwide (all 50 states) Speed: Fast days, not weeks Lab kits: Shipped directly to you Spanish-speaking providers: Not available Start your GLP-1 weight loss journey with Ro today Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice

Both medications require a prescription, and eligibility depends on a patients medical history and treatment goals, Dr

[DOI] [PubMed] [Google Scholar] 51.Taher J, Baker CL, Cuizon C, Masoudpour H, Zhang R, Farr S, et al

They can reduce levels of inflammatory biomarkers, such as C-reactive protein and inflammatory cytokines (eg, tumor necrosis factor-alpha and interleukin-6).100,101 This positively impacts various pathophysiological conditions, including type 2 diabetes, obesity, and non-alcoholic fatty liver disease.100102 In addition, inflammatory cytokines are reportedly involved in CYP gene expression, with the reduced cytokine levels-mediated by GLP-1 RA administration may alter CYP gene expression, potentially leading to changes in the pharmacokinetics of co-administered drugs (Figure 3).213 Finally, cardiovascular outcome trials have demonstrated that GLP-1 RAs offer beneficial effects on kidney function in type 2 diabetes and decrease the risk of major adverse kidney events in patients with type 2 diabetes and acute kidney disease.99,214 These renoprotective effects are expected to be driven by both direct and indirect mechanisms including reducing albuminuria, reducing inflammation, natriuresis and diuresis induction, and antioxidative effects.215 Moreover, GLP-1 RA treatment reportedly increased renal plasma flow and GFR in rats, leading to natriuresis and diuresis.216 It is known that changes in GFR can affect the elimination of many drugs including narrow therapeutic index drugs (aminoglycosides, lithium, digoxin), diuretics, and nonsteroidal anti-inflammatory drugs.217221 Therefore, pharmacokinetic changes in drugs mediated by increased GFR and renal plasma flow following GLP-1 RA administration may occur, and the impact of its mechanism of action need to be investigated in the future